News
The team developed 5n, a potential prostate cancer inhibitor, to disrupt the disease's survival tactics through molecular sabotage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results